rawfin.tv
Revvity Launches Cloud-Native Molecular Cloning Platform Signals BioDesign
TechnologytechAI Generated

Revvity Launches Cloud-Native Molecular Cloning Platform Signals BioDesign

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Revvity, Inc. has debuted Signals BioDesign, a new cloud-native molecular cloning platform. The tool aims to streamline biologics research and development by managing up to 1,000 constructs within a single application.

RVTYBiotechnologyCloud SoftwareProduct LaunchLife Sciences

Related Articles

Anthropic S-1 Filing Reveals $80.7 Billion First-Half Loss Ahead of IPO

Anthropic S-1 Filing Reveals $80.7 Billion First-Half Loss Ahead of IPO

tech
Apple Partners with Meta to Run 816-Billion AI Model Locally

Apple Partners with Meta to Run 816-Billion AI Model Locally

tech
Nvidia Market Share in China AI Chips Drops to 34 Percent as Huawei Gains Ground

Nvidia Market Share in China AI Chips Drops to 34 Percent as Huawei Gains Ground

tech
Nvidia Market Share in China Declines as Huawei Expands AI Chip Reach

Nvidia Market Share in China Declines as Huawei Expands AI Chip Reach

tech